Prostate Cancer Reports
54

Volume 6 Number 9
September 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 9, September



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT





DIAGNOSIS

.

Cimadamore A, Scarpelli M, Cheng L, Lopez-Beltran A, Montorsi F, Montironi R.
Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656-61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists.
Eur Urol. 2018 Aug 6. pii: S0302-2838(18)30556-6. doi: 10.1016/j.eururo.2018.07.034. [Epub ahead of print]
Source | Full text | Similar articles



.

Das CJ, Razik A, Sharma S.
Positron emission tomography in prostate cancer: An update on state of the art.
Indian J Urol. 2018 Jul-Sep;34(3):172-179. doi: 10.4103/iju.IJU_320_17.
Source | Full text | Similar articles



.

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May.
Source | Book | Similar articles



.

Gaur S, Turkbey B.
Prostate MR Imaging for Posttreatment Evaluation and Recurrence.
Urol Clin North Am. 2018 Aug;45(3):467-479. doi: 10.1016/j.ucl.2018.03.011.
Source | Full text | Similar articles



.

Giesel FL, Knorr K, Spohn F, Will L, Maurer T, Flechsig P, Neels O, Schiller K, Amaral H, Weber W, Schwaiger M, Hohenfellner M, Kratochwil C, Debus J, Haberkorn U, Choyke P, Kramer V, Kopka K, Eiber M.
Detection efficacy of [18F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy.
J Nucl Med. 2018 Jul 24. pii: jnumed.118.212233. doi: 10.2967/jnumed.118.212233. [Epub ahead of print]
Source | Full text | Similar articles



.

Kasson M, Ortman M, Gaitonde K, Verma S, Sidana A.
Imaging Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: Past, Present, and Future.
Semin Roentgenol. 2018 Jul;53(3):200-205. doi: 10.1053/j.ro.2018.04.008. Epub 2018 Apr 25.
Source | Full text | Similar articles



.

Rahbar K, Afshar-Oromieh A, Seifert R, Wagner S, Schäfers M, Bögemann M, Weckesser M.
Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.
Eur J Nucl Med Mol Imaging. 2018 Jul 20. doi: 10.1007/s00259-018-4089-x. [Epub ahead of print]
Source | Full text | Similar articles



.

Thompson IM Jr.
The pendulum swings back: Screening for prostate cancer in 2018.
Cancer. 2018 Jul 1;124(13):2690-2692. doi: 10.1002/cncr.31555. Epub 2018 May 22.
Comment on: Negoita S et al, Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. [Cancer. 2018 Jul 1]
Source | Full text | Similar articles



.

van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L.
68Ga PSMA PET/CT predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate and high-risk prostate cancer.
BJU Int. 2018 Aug 3. doi: 10.1111/bju.14506. [Epub ahead of print]
Source | Full text | Similar articles



.

Ward RD, Purysko AS.
Multiparametric Magnetic Resonance Imaging in the Evaluation of Prostate Cancer Recurrence.
Semin Roentgenol. 2018 Jul;53(3):234-246. doi: 10.1053/j.ro.2018.04.002. Epub 2018 Apr 5.
Source | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

.

Barber LE, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn TU, Giovannucci EL, Parmigiani G, Mucci LA.
Family history of breast or prostate cancer and prostate cancer risk.
Clin Cancer Res. 2018 Aug 6. pii: clincanres.0370.2018. doi: 10.1158/1078-0432.CCR-18-0370. [Epub ahead of print]
Source | Full text | Similar articles



.

Benli E, Cirakoglu A, Ayyıldız SN, Yüce A.
Comparison of serum uric acid levels between prostate cancer patients and a control group.
Cent European J Urol. 2018;71(2):242-247. doi: 10.5173/ceju.2018.1619. Epub 2018 Jun 12.
Source | Full text | Similar articles



.

Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, Kohler BA, Jemal A.
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22.
Source | Full text | Similar articles



.

Kogevinas M, Espinosa A, Castelló A, Gómez-Acebo I, Guevara M, Martin V, Amiano P, Alguacil J, Peiro R, Moreno V, Costas L, Fernández-Tardón G, Jimenez JJ, Marcos-Gragera R, Perez-Gomez B, Llorca J, Moreno-Iribas C, Fernández-Villa T, Oribe M, Aragones N, Papantoniou K, Pollán M, Castano-Vinyals G, Romaguera D.
Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study).
Int J Cancer. 2018 Jul 17. doi: 10.1002/ijc.31649. [Epub ahead of print]
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

van Dessel LF, Reuvers SHM, Bangma CH, Aluwini S.
Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes.
Clin Transl Radiat Oncol. 2018 May 29;11:26-32. doi: 10.1016/j.ctro.2018.05.001. eCollection 2018 Jun.
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Beaver LM, Lӧhr CV, Clarke JD, Glasser ST, Watson GW, Wong CP, Zhang Z, Williams DE, Dashwood RH, Shannon J, Thuillier P, Ho E.
Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice.
Curr Dev Nutr. 2018 Mar; 2(3): nzy002. doi: 10.1093/cdn/nzy002. eCollection 2018 Mar. Published online 2017 Dec 26.
Source | Full text | Similar articles



.

Camacho L, Zabala-Letona A, Carracedo A.
Re-evaluating statin activity in cancer.
Aging (Albany NY). 2018 Jul 22;10(7):1538-1539. doi: 10.18632/aging.101504.
Source | Full text | Similar articles



.

Gevariya N, Besançon M, Robitaille K, Picard V, Diabaté L, Alesawi A, Julien P, Fradet Y, Bergeron A, Fradet V.
Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.
Prostate. 2018 Aug 2. doi: 10.1002/pros.23706. [Epub ahead of print]
Source | Full text | Similar articles



OVERALL MANAGEMENT

.

Lowrance WT, Murad MH, Oh WK, Jarrard DF, Resnick MJ, Cookson MS.
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
J Urol. 2018 Aug 6. pii: S0022-5347(18)43671-3. doi: 10.1016/j.juro.2018.07.090. [Epub ahead of print]
Source | Full text | Similar articles



PROGNOSIS

.

Bandini M, Fossati N, Briganti A.
Nomograms in urologic oncology, advantages and disadvantages.
Curr Opin Urol. 2018 Aug 7. doi: 10.1097/MOU.0000000000000541. [Epub ahead of print]
Source | Abstract | Similar articles



.

Dean LW, Assel M, Sjoberg DD, Vickers AJ, Al-Ahmadie HA, Chen YB, Gopalan A, Sirintrapun SJ, Tickoo SK, Eastham JA, Scardino PT, Reuter VE, Ehdaie B, Fine SW.
Clinical utility of total length Gleason pattern 4 on biopsy in men with Grade Group 2 prostate cancer.
J Urol. 2018 Aug 1. pii: S0022-5347(18)43632-4. doi: 10.1016/j.juro.2018.07.062. [Epub ahead of print]
Source | Abstract | Similar articles



.

Galla A, Maggio A, Delmastro E, Garibaldi E, Gabriele P, Bresciani S, Di Dia A, Stasi M, Gabriele D.
Salvage radiation therapy after radical prostatectomy: survival analysis.
Minerva Urol Nefrol. 2018 Jul 23. doi: 10.23736/S0393-2249.18.03124-7. [Epub ahead of print]
Source | Abstract | Similar articles



.

Montironi R, Cheng L, Cimadamore A, Lopez-Beltran A.
Prostate Cancer Grading: Are We Heading Towards Grade Grouping Version 2?
Eur Urol. 2018 Aug 6. pii: S0302-2838(18)30555-4. doi: 10.1016/j.eururo.2018.07.033. [Epub ahead of print]
Comment on: Zhou et al, How Are Gleason Scores Categorized in the Current Literature: An Analysis and Comparison of Articles Published in 2016-2017. Eur Urol. 2018 Jul 26.
Source | Full text | Similar articles



.

Montironi R, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Santoni M, Briganti A, Montorsi F, Cheng L.
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?
Diagn Pathol. 2014 Oct 18;9:190. doi: 10.1186/s13000-014-0190-z.
Source | Full text | Similar articles



.

Xu H, Zhu Y, Dai B, Ye DW.
National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients.
Asian J Androl. 2018 Jul 13. doi: 10.4103/aja.aja_52_18. [Epub ahead of print]
Source | Full text | Similar articles



.

Zhou AG, Salles DC, Samarska IV, Epstein JI.
How Are Gleason Scores Categorized in the Current Literature: An Analysis and Comparison of Articles Published in 2016-2017.
Eur Urol. 2018 Jul 26. pii: S0302-2838(18)30543-8. doi: 10.1016/j.eururo.2018.07.021. [Epub ahead of print]
Source | Full text | Similar articles



TREATMENT

.

Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA.
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.
Lancet Oncol. 2018 Aug;19(8):1051-1060. doi: 10.1016/S1470-2045(18)30357-7. Epub 2018 Jul 12.
Source | Full text | Similar articles



.

Dal Pra A, Abramowitz MC, Stoyanova R, Pollack A.
Contemporary role of postoperative radiotherapy for prostate cancer.
Transl Androl Urol. 2018 Jun;7(3):399-413. doi: 10.21037/tau.2018.06.01.
Source | Full text | Similar articles



.

Lieng H, Hayden AJ, Christie DRH, Davis BJ, Eade TN, Emmett L, Holt T, Hruby G, Pryor D, Shakespeare TP, Sidhom M, Skala M, Wiltshire K, Yaxley J, Kneebone A.
Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group.
Radiother Oncol. 2018 Jul 20. pii: S0167-8140(18)33342-5. doi: 10.1016/j.radonc.2018.06.027. [Epub ahead of print]
Source | Full text | Similar articles



.

Xu L, Pachynski RK.
Contemporary Management of the Newly Diagnosed Prostate Cancer Patient with Metastatic Disease at Presentation.
Curr Urol Rep. 2018 Aug 13;19(10):79. doi: 10.1007/s11934-018-0835-7.
Source | Full text | Similar articles